vimarsana.com

Page 30 - செனட் பெரும்பான்மை தலைவர் ம்க்காநெல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bipartisan Lawmakers Propose $908 Billion in Spending on Relief

Covid-19 Relief Plan Splits Key Aid, Most Contentious Items Bloomberg 12/15/2020 Laura Litvan and Erik Wasson (Bloomberg) A bipartisan group of lawmakers released proposed Covid-19 relief legislation that may provide momentum for breaking a months-long impasse, by separating out coronavirus liability protections and state aid the two most contentious and partisan items. After Republicans and Democrats failed to come to a consensus on a liability shield for employers, the group that has been working on a bipartisan compromise released two separate legislative proposals. One is for $748 billion and includes areas of accord like vaccine funding and aid to small businesses, and the other wraps the two most contentious items, including $160 billion for regional authorities.

Operation Warp Speed chief adviser: Hope to immunize 100M people by 1st quarter of 2021

Operation Warp Speed chief adviser: Hope to immunize 100M people by 1st quarter of 2021
foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.

Nearing Vaccine Dulls Roar for Investors as Congress Gets Nowhere on Stimulus

Markets remained flat as Congress still has no relief package, while Pfizer’s vaccine approval seems imminent. New York Stock Exchange traders Edward McCarthy, left, and Robert Charmak work Friday on the floor during the IPO for Delwinds Insurance Acquisition Corp. (Colin Ziemer/New York Stock Exchange via AP) MANHATTAN (CN)  A week after posting record highs across the board, the three major U.S. indices flattened on Friday. By Friday’s closing bell, the Dow Jones Industrial Average managed to eke out a bare profit of 46 points. The S&P 500 and Nasdaq were not so lucky, though they fell only 0.13% and 0.23%, respectively.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.